You must log in to view this page.

Recursion Pharmaceuticals Inc. – Underwriting Agreements

NASDAQ: RXRX
Share price (11/6/26): $3.52
Market cap (11/6/26): $2.192 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

EX-1.1

from 8-K 43 pages Recursion Pharmaceuticals, Inc. 61,540,000 Shares of Class a Common Stock, $0.00001 Par Value Underwriting Agreement

12/34/56

EX-1

from SCHEDULE 13G/A 1 page Ark Investment Management LLC Date: February 3, 2026 By: /S/ Kellen Carter Name: Kellen Carter Title: Chief Compliance Officer Catherine D. Wood Date: February 3, 2026 By: /S/ Catherine D. Wood Name: Catherine D. Wood Title: Chief Executive Officer, Chief Investment Officer

12/34/56

EX-1.91

from 10-K 12 pages Recursion Pharmaceuticals, Inc. Insider Trading Policy

12/34/56

EX-1.1

from 8-K 49 pages Recursion Pharmaceuticals, Inc. 30,769,230 Shares of Class a Common Stock, $0.00001 Par Value Underwriting Agreement

12/34/56

EX-1

from SC 13G ~5 pages Joint Filing Agreement

12/34/56

EX-1

from SC 13D 1 page Exhibit 1 - Joint Filing Agreement

12/34/56

EX-1.1

from S-1/A 43 pages Recursion Pharmaceuticals, Inc. [●] Shares of Class a Common Stock Underwriting Agreement

12/34/56

Recursion Pharmaceuticals Inc. – Underwriting Agreements Watch

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

Recursion Pharmaceuticals Inc. – Underwriting Agreements